| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 383 | 2024 |
| Depression and prostate cancer risk: A Mendelian randomization study X Chen, J Kong, X Diao, J Cai, J Zheng, W Xie, H Qin, J Huang, T Lin Cancer medicine 9 (23), 9160-9167, 2020 | 164 | 2020 |
| Kidney damage causally affects the brain cortical structure: a Mendelian randomization study X Chen, J Kong, J Pan, K Huang, W Zhou, X Diao, J Cai, J Zheng, X Yang, ... EBioMedicine 72, 2021 | 163 | 2021 |
| The global research of artificial intelligence on prostate cancer: a 22-year bibliometric analysis Z Shen, H Wu, Z Chen, J Hu, J Pan, J Kong, T Lin Frontiers in Oncology 12, 843735, 2022 | 86 | 2022 |
| Development of a noninvasive tool to preoperatively evaluate the muscular invasiveness of bladder cancer using a radiomics approach J Zheng, J Kong, S Wu, Y Li, J Cai, H Yu, W Xie, H Qin, Z Wu, J Huang, ... Cancer 125 (24), 4388-4398, 2019 | 81 | 2019 |
| Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation D Yan, W Dong, Q He, M Yang, L Huang, J Kong, H Qin, T Lin, J Huang EBioMedicine 48, 316-331, 2019 | 68 | 2019 |
| A multicenter study to develop a non-invasive radiomic model to identify urinary infection stone in vivo using machine-learning J Zheng, H Yu, J Batur, Z Shi, A Tuerxun, A Abulajiang, S Lu, J Kong, ... Kidney international 100 (4), 870-880, 2021 | 48 | 2021 |
| Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study Z Shen, J Hu, H Wu, Z Chen, W Wu, J Lin, Z Xu, J Kong, T Lin Journal of Translational Medicine 20 (1), 409, 2022 | 47 | 2022 |
| A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study J Kong, J Zheng, J Cai, S Wu, X Diao, W Xie, X Chen, C Liao, H Yu, X Fan, ... Cancer communications 39, 1-13, 2019 | 47 | 2019 |
| Knowledge mapping and research hotspots of immunotherapy in renal cell carcinoma: A text-mining study from 2002 to 2021 K Liu, S Zhao, J Li, Y Zheng, H Wu, J Kong, Z Shen Frontiers in Immunology 13, 969217, 2022 | 21 | 2022 |
| Causes of death in long‐term bladder cancer survivors: A population‐based study J Kong, X Diao, F Diao, X Fan, J Zheng, D Yan, J Huang, H Qin, T Lin Asia‐Pacific Journal of Clinical Oncology 15 (5), e167-e174, 2019 | 20 | 2019 |
| Knowledge mapping and current trends of immunotherapy for prostate cancer: a bibliometric study W Zhong, Z Shen, Y Wu, X Mao, J Kong, W Wu Frontiers in Immunology 13, 1014981, 2022 | 17 | 2022 |
| Poly C binding protein 1 regulates p62/SQSTM1 mRNA stability and autophagic degradation to repress tumor progression W Zhang, S Zhang, W Guan, Z Huang, J Kong, C Huang, H Wang, S Yang Frontiers in genetics 11, 930, 2020 | 17 | 2020 |
| Metastatic phosphatase PRL-3 induces ovarian cancer stem cell sub-population through phosphatase-independent deacetylation modulations M Zhang, Y Wei, Y Liu, W Guan, X Zhang, J Kong, H Li, S Yang, H Wang IScience 23 (1), 2020 | 17 | 2020 |
| Development of a radiomics model to diagnose pheochromocytoma preoperatively: a multicenter study with prospective validation J Kong, J Zheng, J Wu, S Wu, J Cai, X Diao, W Xie, X Chen, H Yu, ... Journal of translational medicine 20 (1), 31, 2022 | 15 | 2022 |
| Predictive value of dynamic change of haemoglobin levels during therapy on treatment outcomes in patients with Enneking stage IIB extremity osteosarcoma J Tu, L Wen, Z Huo, B Wang, Y Wang, H Liao, W Liu, X Zhong, J Kong, ... Bmc Cancer 18, 1-8, 2018 | 12 | 2018 |
| Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis Y Huang, Z Chen, G Shen, S Fang, J Zheng, Z Chi, Y Zhang, Y Zou, ... Human Vaccines & Immunotherapeutics 20 (1), 2318815, 2024 | 10 | 2024 |
| m6A methylation regulators as predictors for treatment of advanced urothelial carcinoma with anti-PDL1 agent J Kong, S Lu, L Zhang, Y Yao, J Zhang, Z Shen, M Luo, B Liu, J Zheng, ... Frontiers in Immunology 13, 1014861, 2022 | 9 | 2022 |
| A prognostic model of bladder cancer based on metabolism-related long non-coding RNAs J Hu, C Lai, Z Shen, H Yu, J Lin, W Xie, H Su, J Kong, J Han Frontiers in Oncology 12, 833763, 2022 | 9 | 2022 |
| Urban index and lifestyle risk factors for cardiovascular diseases in China: A cross-sectional study Z Chen, M Liu, S Zhang, Z Xiong, X Zhong, D Yang, J Kong, X He, Y Zhu, ... Science progress 104 (1), 00368504211003762, 2021 | 9 | 2021 |
